Bo-Shiun Lai

Molecular Biology · 2019

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Bo-Shiun Lai trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Wenhu Zhou

Papers from Bo-Shiun Lai's perspective

Ordered by how strongly the researchers Bo-Shiun Lai trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease (Nature reviews. Drug discovery)
  2. VEGF INHIBITION STUDY IN OCULAR NEOVASCULARIZATION CLINICAL TRIAL GROUP. PEGAPTANIB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
  3. Directed Polymerase Evolution
  4. Development of DNA aptamers using Cell-SELEX (Nature Protocols)
  5. Aptamers as targeted therapeutics: current potential and challenges (Nature reviews. Drug discovery)
  6. Ultrafine Graphene Nanomesh with Large On/Off Ratio for High‐Performance Flexible Biosensors
  7. Discovery and Development of the G-rich Oligonucleotide AS1411 as a Novel Treatment for Cancer (Experimental and molecular pathology (Print))
  8. Aptamer-based biosensors for biomedical diagnostics. (In Analysis)
  9. Vedolizumab as induction and maintenance therapy for Crohn's disease. (New England Journal of Medicine)
  10. MicroRNA genes are transcribed by RNA polymerase II (EMBO Journal)

Their papers